arrow
F

Fabio Benedetti

University of Trieste
H指数:38
被引数:8,632

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Long-Term Single-Surgeon Outcomes of 320 Robotic Colorectal Cancer Resections: Safety, Oncologic Reliability, and Cost-Effectiveness

320例机器人结直肠癌切除术的长期单外科医师结果:安全性、肿瘤学可靠性和成本效益

2025-12-080
PRE
In Vitro and In Vivo Evaluation of the Effects of Drug 2c and Derivatives on Ovarian Cancer Cells

药物2c及其衍生物对卵巢癌细胞作用的体内外评价

2024-05-150
OAAI
Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network
LANCET
IF88.5
2024-05-0113
OAAI
Identification and evaluation of antiviral activity of novel compounds targeting SARS-CoV-2 virus by enzymatic and antiviral assays, and computational analysis

通过酶和抗病毒试验鉴定和评估靶向SARS CoV-2病毒的新型化合物的抗病毒活性,并进行计算分析

2024-01-140
OAAI
Influence of invasive aspergillosis during acute leukaemia treatment on survival after allogeneic stem cell transplantation: a prospective study of the EBMT Infectious Diseases Working Party
2024-01-013
OAAI
Romidepsin-CHOEP followed by high-dose chemotherapy and stem-cell transplantation in untreated Peripheral T-Cell Lymphoma: results of the PTCL13 phase Ib/II study
LEUKEMIA
IF13.4
2023-01-1818
OAAI
Treosulfan compared with reduced-intensity busulfan improves allogeneic hematopoietic cell transplantation outcomes of older acute myeloid leukemia and myelodysplastic syndrome patients: Final analysis of a prospective randomized trial
2022-06-0832
OA
Lentiviral correction of enzymatic activity restrains macrophage inflammation in adenosine deaminase 2 deficiency
2021-08-2023
OA
Allelic HLA Matching and Pair Origin Are Favorable Prognostic Factors for Unrelated Hematopoietic Stem Cell Transplantation in Neoplastic Hematologic Diseases: An Italian Analysis by the Gruppo Italiano Trapianto di Cellule Staminali e Terapie Cellulari, Italian Bone Marrow Donor Registry, and Associazione Italiana di Immunogenetica e Biologia dei Trapianti

等位基因HLA匹配和配对起源是肿瘤血液病中无关造血干细胞移植的有利预后因素: 意大利骨髓捐献者登记处Gruppo Italiano Trapianto di Cellule Staminali e Terapie Cellulari,意大利骨髓捐献者登记处和意大利免疫遗传学协会的一项意大利分析

2021-05-015
OAAI
Neutropenia and survival outcomes in metastatic colorectal cancer patients treated with trifluridine/tipiracil in the RECOURSE and J003 trials
2020-01-0146
OAAI
Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial
2020-01-0198
PREAI
Strategies for Delivery of siRNAs to Ovarian Cancer Cells

将siRNAs递送至卵巢癌细胞的策略

2019-10-2220
OAAI
Comparative evaluation of biological human leukocyte antigen DPB1 mismatch models for survival and graft-versus-host disease prediction after unrelated donor hematopoietic cell transplantation
2019-08-3014
OAAI
Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial

晚期滤泡性淋巴瘤化疗免疫治疗后无疾病复发的延长生存期: 前瞻性,多中心随机gitmo-iil试验的13年更新

2019-04-1111
OAAI
Acute GVHD prophylaxis plus ATLG after myeloablative allogeneic haemopoietic peripheral blood stem-cell transplantation from HLA-identical siblings in patients with acute myeloid leukaemia in remission: final results of quality of life and long-term outcome analysis of a phase 3 randomised study
2019-02-0146
PREAI
Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

Brentuximab vedotin联合化疗治疗CD30-positive外周T细胞淋巴瘤 (ECHELON-2): 一项全球性、双盲、随机、3期临床试验

LANCET
IF88.5
2019-01-01535
OAAI